Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
6.69
+0.20 (3.08%)
Aug 14, 2025, 2:25 PM - Market open
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $585.45 million as of August 14, 2025. Its market cap has increased by 8.67% in one year.
Market Cap
585.45M
Enterprise Value
253.63M
1-Year Change
8.67%
Ranking
Category
Stock Price
$6.69
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $585.45M, an increase of 307.66%. That is a compound annual growth rate of 36.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 567.95M | 20.70% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
| Feb 5, 2021 | 143.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |